New Nordic Healthbrands AB (publ) has decided to postpone the application for listing on Nasdaq Main Market Stockholm
NEW NORDIC HEALTHBRANDS AB (PUBL) HAS DECIDED TO POSTPONE THE APPLICATION FOR LISTING ON NASDAQ MAIN MARKET STOCKHOLM
New Nordic Healthbrands AB (publ) has decided to postpone the application for listing on Nasdaq Main Market Stockholm. The application will be made late 2022 with the aim to list in 2023
Following our announcement on February 28, 2020, we confirm that we are preparing for listing on Nasdaq Main Market Stockholm.
However, we have decided to postpone the application until the covid situation has eased and the geopolitical and financial situation is more stable and predictable.
We expect that the application will be made late 2022 with the aim to obtain listing 2023..
New Nordic is expanding internationally. A listing on the Nasdaq Main Market will attract more interest in the New Nordic share from international investors and institutional investors.
New Nordic does not currently plan to issue more shares in the company in combination with the listing.
Karl Kristian Bergman Jensen, CEO
New Nordic Healthbrands AB
Hyllie Boulevard 34
SE-215 32 Malmö
Sweden
This information is information that New Nordic Healthbrands AB (publ) is obliged to make public, pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, on 28 February 2022 at 8:00 CET.
Contact:
Karl Kristian Bergman Jensen, CEO, telephone +46 40-236414, e-mail [email protected].
Ivan Ruscic, CFO, telephone +46 40-236414, e-mail [email protected]
Claes Libell, Group Financial Controller and Investor Relations, telephone +46 40-236414, e-mail [email protected]
New Nordic Healthbrands AB (publ), SE-215 32 Malmö, Sweden.
Org. nr. 556698-0453.Karl Kristian Bergman Jensen, CEO +46 40-239520 (switchboard).
The following documents can be retrieved from beQuoted
New Nordic Pressrelease 2022-02-28.pdf
New Nordic Healthbrands AB (publ) was founded in 1990 and is listed on Nasdaq First North Growth Market Sweden since 2007. The company's business concept is to offer the most effective and safe dietary supplements, natural medicines and cosmetic products for specific health and beauty needs. All with care for people and nature. New Nordic products are now available in 41 countries in pharmacies, health stores, beauty shops, and travel retail. New Nordic has its own small sales and marketing companies in most European countries, Canada and the United States, to organise local marketing campaigns, serve retailers and serve end customers. In 2021, revenues were SEK 515 million. Almost all New Nordic products sold worldwide are manufactured in Scandinavia. For more information, visit www.newnordic.com.
